HB 1426 creates a new permit for clinical research pharmacies in Maryland, which are facilities specifically designed to conduct clinical trials. It allows healthcare providers to own these pharmacies under strict conditions, including requiring a licensed pharmacist to be on-site during all operating hours and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations or entities from being classified as "practice of medicine," meaning trial staff no longer need individual medical licenses for their trial-related work. This change aims to streamline clinical research by removing a regulatory barrier that previously required individual licensing for trial staff.
HB 222 requires Maryland public schools and colleges to update policies and education programs to address opioid overdoses. It mandates schools to store naloxone, allow authorized staff and students to possess it, and provide liability protection for good-faith use during overdoses. The bill also adds naloxone's life-saving role to K-12 drug prevention curricula (starting in third grade) and requires annual parent notifications about school naloxone policies. Additionally, schools must report overdose incidents requiring naloxone use to the State Department. This affects all public K-12 schools and state-funded colleges.
HB 417 (Public Health - Medetomidine and Xylazine Consumer Protection Act) regulates the sale of veterinary drugs medetomidine and xylazine. It prohibits retailers from selling these products without proof the buyer intends to use them for veterinary, scientific, or institutional purposes, and bans sales to anyone under 21. Retailers must maintain records of sales, including age verification and proof of intended use. Violations carry civil fines up to $6,500 per offense, with penalties deposited into Maryland's Substance Abuse Fund. The bill directly affects pharmacies, veterinary suppliers, and online retailers selling these specific products.
HB 1167 requires Maryland's Department of Health to replace its outdated Medicaid computer system with a modern, flexible system by 2028. The new system must maintain all current Medicaid functions - including processing medical/dental/pharmacy claims, provider enrollment, and beneficiary inquiries - while meeting federal security and performance standards. The bill mandates integration with existing Medicaid systems by January 2027 and full replacement of the old system by January 2028, subject to federal approval. This change directly affects Medicaid beneficiaries and healthcare providers through more reliable service delivery.
SB 515 requires Maryland's Health Services Cost Review Commission to consider all operational costs incurred by health facilities - including expenses for physicians and other providers without corresponding billing revenue - when setting hospital rates. This affects hospitals and health facilities operating under Maryland's all-payer model, as the Commission must now factor in full costs during rate reviews. The bill amends existing law to mandate that the Commission evaluate facility financial health and certify rates based on complete cost accounting, rather than excluding certain expenses. This change ensures rates more accurately reflect actual facility operations, including costs for professional services that previously weren't fully counted.
HB 1014 defines "danger to the life or safety of the individual or of others" for Maryland's mental health law, directly affecting individuals with mental disorders who might face involuntary admission. It specifies four concrete scenarios that constitute this danger: causing bodily harm, engaging in conduct leading to criminal involvement, inability to meet basic needs (food, shelter, medical care), or substantial deterioration in judgment that impairs treatment decisions. The definition requires a "substantial risk" considering the person's current condition and available history, replacing the prior standard. This change clarifies the legal threshold for involuntary hospitalization and emergency evaluations under Maryland law.
This bill updates Maryland's newborn screening program by changing how fees are set and how new tests are added to the screening panel. It requires the Department of Health to charge fees that cover all administrative, laboratory, and follow-up costs rather than setting a specific maximum amount. The bill also establishes a process where an advisory council must review risks, costs, and accessibility before the department decides whether to test for new conditions added to the national screening panel. Additionally, it extends the timeline for implementing new tests to two years if equipment or supplies are delayed, with required reporting to state committees.
HB 860, the Arnaud and Magruder Memorial Act, sets a 5-day initial limit for emergency evaluation petitions after court approval, with extensions of up to 5 days each (totaling no more than 30 days) based on the individual's current behavior. The bill requires courts to include the petition's expiration date and clarifies that peace officers must transport individuals to emergency facilities when holding a valid petition (either court-endorsed within 5 days or signed by authorized professionals), allowing electronic petitions. This law directly affects courts reviewing petitions, peace officers executing them, emergency facilities receiving individuals, and people subject to emergency evaluations. It standardizes timelines and procedures to ensure timely care while preventing prolonged detention without court review.
HB 1593 requires Maryland's Deputy Secretary for Developmental Disabilities to provide public notice before changing the Self-Directed Services Manual, which governs waiver program services for individuals with developmental disabilities. The bill mandates a 90-day public comment period for proposed changes and prohibits adopting any revisions until this period ends. It directly affects individuals and families using self-directed services - where participants control their own care choices, staffing, and budget management - and ensures their input is considered before policy changes take effect. This procedural bill amends Maryland’s health code to formalize transparency and public engagement in updating the manual (effective October 1, 2026).
HB 837 requires all Maryland public and nonpublic schools with athletic programs to include a cardiovascular prescreening as part of the standard physical examination for students participating in interscholastic sports, starting in the 2026-2027 school year. This prescreening - based on family history, personal symptoms, and evidence-based guidelines - must be conducted no earlier than 90 days before the school year begins. If a positive finding occurs, healthcare providers must refer students to a cardiologist for further evaluation. Schools must report annual data on screenings and referrals to county health departments, with the Maryland Department of Health publishing public reports analyzing outcomes. The bill directly affects student athletes, schools, and healthcare providers conducting sports physicals.